We are the future of genetic testing. At CircaGene, we want people to have the information to prevent health predispositions. We deliver hyper-personalised genetic analysis to each individual to give accurate and scientific validated information so the user can prevent and proactively manage their health making decisions. This can not only might change their life, and lifestyle but also, in some cases, even to save their life!
Founders François Paillier and Jackeline Palma worked before in a $52MDll project delivering to BARDA (Biomedical Advanced Research and Development Authority) a division of the US Government Department of Health and Human Services.
They were working together on the development of a next-generation sequencing (NGS) platform for rapid diagnosis of antimicrobial-resistant infections and influenza. As part of the team, they successfully sequenced the DNA of bacteria directly from an unprocessed blood sample. This has not been possible with any sequencing technologies until this project. After two years of working together, they decided to start their own company on genetic testing. Bringing genomics and DNA sequencing closer to the customer, founders believe they will transform the pathway not only with the hyper-personalized analysis per customer but also pioneering in a new standard on DNA data privacy for the world to adopt.
Their passion is health prevention, ageing healthy and help everyone that has a genetic disorder to provide actionable information to clinicians, saving lives by enabling the right action at the right time.